ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,305, issued on April 7, was assigned to Novartis AG (Basel, Switzerland). "TREM2 stabilizing antibodies" was invented by Verena Brand (Muni... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,306, issued on April 7, was assigned to Novartis AG (Basel, Switzerland). "TREM2 stabilizing antibodies" was invented by Verena Brand (Muni... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,307, issued on April 7, was assigned to NantBio Inc. (Culver City, Calif.). "Anti-CTLA4 monoclonal antibodies and chimeric antigen receptor... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,308, issued on April 7, was assigned to GUANGZHOU BIO-GENE TECHNOLOGY Co. LTD (Guangdong, China). "Anti-B7H3 antibody and use thereof" was ... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,309, issued on April 7, was assigned to Viridian Therapeutics Inc. (Waltham, Mass.). "Compositions and methods for treatment of thyroid eye... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,310, issued on April 7, was assigned to The Regents of the University of California (Oakland, Calif.). "Compositions and methods for transf... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,311, issued on April 7, was assigned to The Regents of the University of California (Oakland, Calif.). "Chimeric antigen receptors and rela... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,312, issued on April 7, was assigned to The Governing Council of the University of Toronto (Toronto) and McMaster University (Hamilton, Cana... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,313, issued on April 7, was assigned to Scancell Ltd. (Oxford, Great Britain). "Modified Fc-regions to enhance functional affinity of antib... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,314, issued on April 7, was assigned to R.P. Scherer Technologies LLC (Carson City, Nev.). "Antibody specific for GPC3 and methods of use t... Read More